NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Thiol-based regulation of glyceraldehyde-3-phosphate dehydrogenase in blood bank-stored red blood cells: a strategy to counteract oxidative stress.

Author(s): Rinalducci S, Marrocco C, Zolla L

Publication: Transfusion, 2015, Vol. 55, Page 499-506

PubMed ID: 25196942 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of refrigerated storage on glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels and molecular modification in red blood cell (RBC) membranes and cytosol.

Conclusion of Paper

During storage of RBCs, GAPDH moved from the RBC membrane to the cytosol and then back to the membrane. In addition, on day 21 of storage, cytosolic GAPDH had an intramolecular disulfide bond that was not present on day 0 which, the authors postulate, may cause a reversible inactivation of the molecule.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of refrigerated storage on GAPDH levels and molecular modification in RBC membranes and cytosol. Leukoreduced RBCs in saline-adenine-glucose-mannitol (SAGM) were obtained from 5 healthy donors and stored at 4°C.

    Summary of Findings:

    Cytosolic GAPDH activity increased rapidly between day 0 and day 7 of refrigerated storage of RBCs (p<0.001) and was slightly higher on day 14 than day 7 of storage but was lower on day 21 than on day 0 (p<0.001). A slight increase in GAPDH activity was observed between day 21 and day 42 of RBC storage such that on day 42, GAPDH activity was slightly higher than on day 0 (p<0.01). Western blot analysis showed that membrane bound GAPDH decreased while cytosolic GAPDH increased during the first 14 days of refrigerated storage of RBCs (p<0.001, both), but that after 28 days, levels of GAPDH in the cytosol were comparable to those on day 0, and levels of GAPDH in the membranes were higher than on day 0 (p<0.001). Under non-reducing conditions, no GAPDH aggregates were observed in the cytosolic or membrane fractions, but an intramolecular disulfide bond between cysteine 152 and 156 was found in cytosolic GAPDH on day 21, but not day 0 of storage. The authors state this intramolecular disulfide bond may cause a reversible inactivation of GAPDH.

    Biospecimens
    Preservative Types
    • Other Preservative
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein LC-ESI-MS/MS
    Protein Colorimetric assay
    Protein Western blot
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Western blot Specific Targeted peptide/protein GAPDH
    Storage Storage duration 0 days
    7 days
    14 days
    21 days
    28 days
    35 days
    42 days

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...